Article
Precision Therapy for Brain Tumors in Hereditary Syndromes.
Current treatment options in oncology - 2 Jul 2021
Wallace Gerald C, Tjoelker Madeleine, Bartley Kaitlyn, Henson John W
Abstract excerpt
OPINION STATEMENT: Nervous system tumors arising in the setting of monogenic, hereditary cancer predisposition syndromes are unique in that the initiating genetic event in tumor formation is known. This knowledge provides a powerful treatment approach if the alteration or pathway can be targeted with a therapeutic agent. A reasonable argument can be made for the use of targeted agents in these tumor patients,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
